Vieworks, a leading global provider of high-performance digital x-ray imaging solutions, has participated in ECR 2023 to showcase its latest range of products from static to dynamic x-ray flat panel detectors (FPD) for various medical applications.
Chest pathologies detection is the first in a new range of functionalities embedded in the MUSICA® Workstation to assist clinicians and radiology department staff in detecting critical pathologies within seconds after the X-ray exam.
It is proven and widely accepted that mammography is an essential tool in breast cancer screening. Over the years, the development of the technology used to image breast tissue has enabled breast cancer to be detected earlier and more often.
What’s considered normal body temperature varies from person to person, yet overall, the average basal temperature of the human body has decreased since the 1860s for unknown reasons. A study points to the gut microbiome as a potential regulator of body temperature, both in health and during life-threatening infections.
A Michigan Medicine study [1] suggests that hospitals without the highest stroke care designation may be missing strokes that occur after a common heart valve replacement procedure.
During the holidays, kids often spend more time on screens, leaving parents to wonder: Is it causing harm? Possibly.
Allen Institute’s Hongkui Zeng receives prestigious Pradel Research Award from National Academy of Sciences for pioneering work in neuroscience
Prof. Aidan Hollis wins first £40,000 OHE Policy Innovation Prize to devise a globally applicable approach to fair pricing of medicines
MDimune, a Korean biotech company developing BioDrone platform technology based on cell-derived vesicles (CDVs), has received funding for two research projects focusing on next-generation drug delivery and novel therapeutics. The projects were selected through the 3rd BioDrone Award held in October 2022. For these projects, MDimune signed an MoU with Hanyang University to collaborate with […]
Pfizer has significantly expanded its commitment to An Accord for a Healthier World to offer the full portfolio of medicines and vaccines for which it has global rights on a not-for-profit basis to enable greater health for 1.2 billion people living in 45 lower-income countries.
April 2024
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.